 Ou, Sai-Hong Ignatius
|
|
| Title | Health Sciences Professor |
|---|
| Institution | University of California, Irvine |
|---|
| Department | Medicine |
|---|
| Address | 1001 Health Sciences Road
Irvine CA 92697-3950
|
|---|
| Phone | (714) 456-5153 |
|---|
| vCard | Download vCard |
|---|
|
|
 Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Researchers can login to make corrections and additions, or contact us for help.
-
Ou SI, Govindan R, Eaton KD, Otterson GA, Gutierrez ME, Mita AC, Argiris A, Brega NM, Usari T, Tan W, Ho SN, Robert F. Phase I Results from a Study of Crizotinib in Combination with Erlotinib in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer. J Thorac Oncol. 2017 01; 12(1):145-151. PMID: 27697581.
-
Ou SH, Pasi J. Reply to the letter to the editor 'clinical benefit of continuing ALK inhibition with crizotinib beyond initial disease progression in patients with advanced ALK-positive NSCLC' by Ou et al. Ann Oncol. 2014 Oct; 25(10):2093. PMID: 25035278.
-
Ou SH. Second-generation irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs): a better mousetrap? A review of the clinical evidence. Crit Rev Oncol Hematol. 2012 Sep; 83(3):407-21. PMID: 22257651.
-
Ou SI, Zell JA. The effect of tumor size on non-size-based descriptors in staging of stage I non-small cell lung cancer. Chest. 2009 Jun; 135(6):1695-1696. PMID: 19497911.
|
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Related Authors People who share related concepts with this person. _
|